ESC 365 - Ferric carboxymaltose in heart failure with iron deficiency - the HEART-FID and AFFIRM-AHF trials

Open Access

Ferric carboxymaltose in heart failure with iron deficiency - the HEART-FID and AFFIRM-AHF trials

Session: Trials of IV iron: what we got right and what we didn’t. How can the new ESC guidelines help improving clinical practice?

Topic: Anaemia/Iron Deficiency

Speaker: Doctor R. Mentz (Durham, US)

Sponsored by Pharmacosmos

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Robert Mentz

Duke University Medical Center, Durham (United States of America)

10 presentations

0 follower

5 more presentations in this session

Welcome and introduction

Speaker: Professor T. McDonagh (London, GB) Professor J. Cleland (Glasgow, GB)

Ferric derisomaltose in heart failure with iron deficiency - an update from the IRONMAN trial

Speaker: Professor P. Kalra (Portsmouth, GB)

What do the new ESC guidelines recommend

Speaker: Professor T. McDonagh (London, GB)

What's still to come

Speaker: Professor J. Cleland (Glasgow, GB)

Q&A

Access the full session

Trials of IV iron: what we got right and what we didn’t. How can the new ESC guidelines help improving clinical practice?

Speakers: Doctor R. Mentz, Professor T. McDonagh, Professor J. Cleland, Professor P. Kalra, Professor T. McDonagh...

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources